uniQure (QURE) Cash from Operations (2016 - 2026)
uniQure (QURE) posted quarterly Cash from Operations of 28576000.0 for Q2 2026, up 28.37% year-over-year from 22260310.07 in Q2 2025, and up 25.28% quarter-over-quarter from 38243000.0 in Q1 2026.
uniQure (QURE) Cash from Operations (2016 - 2026) Analysis & Trends
uniQure's Cash from Operations history runs 11 years deep, the most recent figure standing at 28576000.0 for Q2 2026.
- In Q2 2026, Cash from Operations rose 28.37% year-over-year to 28576000.0; the TTM figure through Jun 2026 stood at 160787000.0 (up 7.29% YoY), while the FY2025 annual figure was 177963000.0, up 2.61% from the prior year.
- Cash from Operations for Q2 2026 stood at 28576000.0, up from 38243000.0 in the prior quarter.
- The five-year high for Cash from Operations was 38911000.0 in Q3 2023, with the low at 78302000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 41997500.0 (2025), against an average of 39916611.11.
- Peak annual rise in Cash from Operations reached 179.42% in 2023, while the deepest fall reached 263.55% in 2023.
- uniQure's Cash from Operations stood at 54680000.0 in 2022, then increased by 9.4% to 49541000.0 in 2023, then declined by 6.67% to 52844000.0 in 2024, then sank by 46.79% to 77569000.0 in 2025, then surged by 63.16% to 28576000.0 in 2026.
- Business Quant data shows QURE's Cash from Operations at 28576000.0 in Q2 2026, 38243000.0 in Q1 2026, and 77569000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | -28.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -28.58 Mn |
| Jun 30, 2026 | -28.58 Mn |
| Mar 31, 2026 | -38.24 Mn |
| Mar 31, 2026 | -38.24 Mn |
| Dec 31, 2025 | -77.57 Mn |
| Dec 31, 2025 | -77.57 Mn |
| Sep 30, 2025 | -16.40 Mn |
| Sep 30, 2025 | -16.40 Mn |
| Jun 30, 2025 | -39.90 Mn |
| Jun 30, 2025 | -39.90 Mn |
| Mar 31, 2025 | -44.10 Mn |
| Mar 31, 2025 | -44.10 Mn |
| Dec 31, 2024 | -52.84 Mn |
| Dec 31, 2024 | -52.84 Mn |
| Sep 30, 2024 | -36.60 Mn |
| Sep 30, 2024 | -36.60 Mn |
| Jun 30, 2024 | -32.71 Mn |
| Jun 30, 2024 | -32.71 Mn |
| Mar 31, 2024 | -60.58 Mn |
| Mar 31, 2024 | -60.58 Mn |